OTIPAX

This brand name is authorized in Estonia, France, Lithuania, Malta, Romania, Tunisia.

Active ingredients

The drug OTIPAX contains a combination of these active pharmaceutical ingredients (APIs):

1	Phenazone UNII T3CHA1B51H - ANTIPYRINE
	Phenazone has analgesic and antipyretic properties. Topically, solutions have been used locally as ear drops in disorders such as otitis media because of its local anti-inflammatory and analgesic action.
	Read more about Phenazone
2	Lidocaine UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S02DA30	Combinations	S Sensory organs → S02 Otologicals → S02D Other otologicals → S02DA Analgesics and anesthetics
Discover more medicines within S02DA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1172506
FR	Base de données publique des médicaments	69668703
LT	Valstybinė vaistų kontrolės tarnyba	1006980
MT	Medicines Authority	MA239/00201
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58408001
TN	Direction de la Pharmacie et du Médicament	5193041, 9013281